Using BIS monitoring to assess sepsis severity in critically ill patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study evaluates the effectiveness of Bispectral Index (BIS) monitoring in classifying the severity of sepsis in critically ill patients. It aims to correlate BIS values with procalcitonin (PCT) graded sepsis levels and other clinical parameters such as C-reactive protein, Glasgow coma scale, and sequential organ failure assessment scores. The study involves measuring BIS values over time to monitor changes in the patient's mental state and sepsis condition. No interventions are administered, as the focus is on observational data collection.

Why it matters

Who can join: the full rules

Inclusion Criteria: patients with sepsis

* patients with sepsis

Exclusion Criteria:

* Patients who received drugs that would interfere with BIS monitoring

Where it's running

• Dalian Medical University
  Dalian, Dalian, China Recruiting

Study contacts

• Principal investigator: Ashraf Dahaba, MD, MSc — Suez Canal University
• Study coordinator: Ashraf Dahaba
• Email: ashraf.dahaba@medunigraz.at
• Phone: 00436509006761

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Investigating how transposable elements affect immune aging in sepsis patients

  This study looks at how certain genetic elements might affect the immune system and health outcomes in people with sepsis in the ICU.

  Recruiting University of California, San Francisco · San Francisco, California · NCT06809868

• Identifying biomarkers for diagnosing sepsis in the emergency room

  This study is trying to find out if certain immune responses can help doctors spot sepsis in patients with infections when they arrive at the emergency room.

  Recruiting at 2 sites Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Almere Stad, Flevoland and 2 other locations · NCT06178822

• Reducing unnecessary vancomycin use in children with suspected sepsis

  This study is testing a new approach to see if better guidelines and education can help doctors use less vancomycin in children suspected of having sepsis, which could lower the risk of kidney problems.

  Recruiting at 4 sites Children's Hospital of Philadelphia · Atlanta, Georgia and 3 other locations · NCT05975671

• Early use of norepinephrine for treating severe sepsis

  This study is testing if giving norepinephrine earlier can help people with severe sepsis feel better and live longer compared to a placebo.

  Recruiting Phase 4 Tunis University · Tunis · NCT05836272

• Evaluating sepsis treatment methods in emergency departments

  This study tests two different treatment plans for sepsis in emergency rooms to see which one helps patients survive and avoid breathing problems better.

  Recruiting Rhode Island Hospital · Providence, Rhode Island · NCT05491941

• Treatment for severe sepsis using immune cell therapy

  This study tests a new immune cell therapy for adults with severe sepsis to see if it can help them recover better alongside standard treatment.

  Recruiting at 18 sites Phase 2 Artcline GmbH · Freiburg im Breisgau, Baden-Wurttemberg and 19 other locations · NCT05442710

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.